An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA–loaded dendritic cells for cancer vaccination

Authors:

Abstract
No abstract available
Funding Information
  • Ghent University Concerted Research Initiative (BOF24/GOA/027)
  • Foundation Against Cancer, the Flemish League Against Cancer, Spearhead Research Programs and Ghent University Hospital Inter-University Attraction Poles

This publication has 52 references indexed in Scilit: